{"id":"https://openalex.org/W2345469147","doi":null,"title":"Inhibition of in vivo tumour growth by the blocking of host alpha(v)beta3 and alphaII(b)beta3 integrins.","display_name":"Inhibition of in vivo tumour growth by the blocking of host alpha(v)beta3 and alphaII(b)beta3 integrins.","alternate_titles":[],"publication_year":2009,"publication_date":"2009-01-01","ids":{"openalex":"https://openalex.org/W2345469147","mag":"2345469147","pmid":"https://pubmed.ncbi.nlm.nih.gov/19331142"},"language":"en","primary_location":{"id":"pmid:19331142","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19331142","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W2345469147"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5050930640","display_name":"Olav Engebraaten","orcid":"https://orcid.org/0000-0002-0986-6957","observed_orcids":["https://orcid.org/0000-0002-0986-6957"]},"institutions":[{"id":"https://openalex.org/I184942183","display_name":"University of Oslo","ror":"https://ror.org/01xtthb56","country_code":"NO","type":"education","lineage":["https://openalex.org/I184942183"]}],"countries":["NO"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Olav Engebraaten","raw_affiliation_strings":["Department of Tumour Biology, Institute for Cancer Research, University of Oslo, Faculty Division, The Norwegian Radium Hospital, Montebello, Oslo, Norway. olav.engebraten@medisin.uio.no"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Tumour Biology, Institute for Cancer Research, University of Oslo, Faculty Division, The Norwegian Radium Hospital, Montebello, Oslo, Norway. olav.engebraten@medisin.uio.no","institution_ids":["https://openalex.org/I184942183"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112719642","display_name":"Mohit Trikha","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mohit Trikha","raw_affiliation_strings":["Centocor, Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centocor, Inc","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083119909","display_name":"Siri Juell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I184942183","display_name":"University of Oslo","ror":"https://ror.org/01xtthb56","country_code":"NO","type":"education","lineage":["https://openalex.org/I184942183"]}],"countries":["NO"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Siri Juell","raw_affiliation_strings":["University of Oslo"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Oslo","institution_ids":["https://openalex.org/I184942183"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025071439","display_name":"Solveig Garman-Vik","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I184942183","display_name":"University of Oslo","ror":"https://ror.org/01xtthb56","country_code":"NO","type":"education","lineage":["https://openalex.org/I184942183"]}],"countries":["NO"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Solveig Garman-Vik","raw_affiliation_strings":["University of Oslo"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Oslo","institution_ids":["https://openalex.org/I184942183"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113522568","display_name":"\u00d8ystein Fodstad","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"\u00d8ystein Fodstad","raw_affiliation_strings":["Institute for Cancer Research"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Cancer Research","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.6846,"has_fulltext":false,"cited_by_count":32,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.71080556,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"29","issue":"1","first_page":"131","last_page":"137"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10831","display_name":"Cell Adhesion Molecules Research","score":0.9150000214576721,"subfield":{"id":"https://openalex.org/subfields/2723","display_name":"Immunology and Allergy"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10831","display_name":"Cell Adhesion Molecules Research","score":0.9150000214576721,"subfield":{"id":"https://openalex.org/subfields/2723","display_name":"Immunology and Allergy"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.08420000225305557,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10620","display_name":"Protease and Inhibitor Mechanisms","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alpha-v-beta3-integrin","display_name":"alpha v beta 3 integrin","score":0.9779999852180481},{"id":"https://openalex.org/keywords/glycoprotein-iib-iiia","display_name":"integrin \u03b1IIb\u03b23","score":0.8619999885559082},{"id":"https://openalex.org/keywords/integrin-blockade","display_name":"integrin blockade","score":0.5950000286102295},{"id":"https://openalex.org/keywords/tumor-angiogenesis","display_name":"tumor angiogenesis","score":0.7590000033378601},{"id":"https://openalex.org/keywords/anti-angiogenic-therapy","display_name":"anti-angiogenic therapy","score":0.8230000138282776},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.7910000085830688},{"id":"https://openalex.org/keywords/bone-tumors","display_name":"bone tumors","score":0.6660000085830688},{"id":"https://openalex.org/keywords/microvessel-density","display_name":"microvessel density","score":0.8330000042915344},{"id":"https://openalex.org/keywords/basic-fibroblast-growth-factor","display_name":"basic fibroblast growth factor","score":0.9539999961853027},{"id":"https://openalex.org/keywords/platelet-activation","display_name":"platelet activation","score":0.7749999761581421},{"id":"https://openalex.org/keywords/nude-rat-model","display_name":"nude rat model","score":0.7329999804496765}],"concepts":[{"id":"https://openalex.org/C195687474","wikidata":"https://www.wikidata.org/wiki/Q409715","display_name":"Integrin","level":3,"score":0.7950541377067566},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.743809700012207},{"id":"https://openalex.org/C2775960820","wikidata":"https://www.wikidata.org/wiki/Q408378","display_name":"Growth factor","level":3,"score":0.574339747428894},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5338662266731262},{"id":"https://openalex.org/C2781294074","wikidata":"https://www.wikidata.org/wiki/Q22327352","display_name":"Platelet-derived growth factor","level":5,"score":0.48398375511169434},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4737860858440399},{"id":"https://openalex.org/C2776436680","wikidata":"https://www.wikidata.org/wiki/Q1632335","display_name":"Microvessel","level":3,"score":0.4498811662197113},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.38752827048301697},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.34914493560791016},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3411358594894409},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3172306418418884},{"id":"https://openalex.org/C180361614","wikidata":"https://www.wikidata.org/wiki/Q7202242","display_name":"Platelet-derived growth factor receptor","level":4,"score":0.2712094783782959},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.25303709506988525},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.22644218802452087},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000098","qualifier_name":"blood supply","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005434","descriptor_name":"Flow Cytometry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006367","descriptor_name":"HeLa Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007128","descriptor_name":"Immunoglobulin Fragments","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D007128","descriptor_name":"Immunoglobulin Fragments","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009362","descriptor_name":"Neoplasm Metastasis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009389","descriptor_name":"Neovascularization, Pathologic","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009389","descriptor_name":"Neovascularization, Pathologic","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D019039","descriptor_name":"Platelet Glycoprotein GPIIb-IIIa Complex","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D019039","descriptor_name":"Platelet Glycoprotein GPIIb-IIIa Complex","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D019039","descriptor_name":"Platelet Glycoprotein GPIIb-IIIa Complex","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D039302","descriptor_name":"Integrin alphaVbeta3","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D039302","descriptor_name":"Integrin alphaVbeta3","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D039302","descriptor_name":"Integrin alphaVbeta3","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D048708","descriptor_name":"Cell Growth Processes","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:19331142","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19331142","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Journal Article"},{"id":"mag:2345469147","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19331142","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9907000064849854,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":1,"referenced_works":["https://openalex.org/W2186153216"],"related_works":["https://openalex.org/W2326136208","https://openalex.org/W2140859605","https://openalex.org/W1974821191","https://openalex.org/W2142580186","https://openalex.org/W147592962","https://openalex.org/W2467559599","https://openalex.org/W2488091599","https://openalex.org/W2410320980","https://openalex.org/W2470362099","https://openalex.org/W2443605913"],"abstract_inverted_index":{"BACKGROUND:":[0],"The":[1,30,122,139],"alpha(v)beta3":[2,76,93],"integrin":[3,33],"in":[4,66,105,119,135,195],"the":[5,12,74,98,102,106,116,125,136,143,146,149,163,172,183,202],"endothelial":[6],"cell":[7],"membrane":[8],"is":[9,22,34],"important":[10,126],"for":[11,27,36,73,193],"growth":[13,65,168],"and":[14,21,48,77,91,94,114,169],"migration":[15],"of":[16,43,84,101,124,148,166,205],"capillaries":[17],"into":[18],"tumour":[19,49,64,70,150,167,179],"tissue":[20],"also":[23,115],"a":[24,157],"survival":[25],"factor":[26,128],"these":[28,120],"cells.":[29],"alphaII(b)beta3":[31,78,95],"(GPIIb/IIIa)":[32],"responsible":[35],"platelet":[37],"activation":[38],"and,":[39],"with":[40,69,197],"concomitant":[41],"release":[42],"different":[44],"stored":[45],"proangiogenic":[46,127],"factors,":[47],"cell-platelet":[50],"interactions.":[51],"MATERIALS":[52],"AND":[53],"METHODS:":[54],"An":[55],"immunodeficient":[56],"nude":[57],"rat":[58,92],"model":[59],"was":[60,130],"used":[61],"to":[62,145,153],"study":[63],"tibial":[67,107],"bone,":[68],"cells":[71],"negative":[72],"target":[75],"integrins.":[79],"RESULTS:":[80],"Daily":[81],"intraperitoneal":[82],"injections":[83],"m7E3":[85],"F(ab')2":[86],"antibody":[87],"fragment,":[88],"blocking":[89],"human":[90],"integrins,":[96],"reduced":[97,132,178],"measured":[99],"size":[100],"tumours":[103],"growing":[104],"bone":[108,173],"by":[109,133],"35%":[110],"(p":[111],"=":[112],"0.012),":[113],"microvessel":[117],"density":[118],"tumours.":[121,138],"concentration":[123],"bFGF":[129],"significantly":[131],"41%":[134],"treated":[137],"treatment":[140,177,187,199],"slightly":[141],"increased":[142],"time":[144],"appearance":[147],"from":[151],"22.2":[152],"24.9":[154],"days,":[155],"indicating":[156],"small":[158],"but":[159],"significant":[160],"effect":[161],"on":[162],"early":[164],"stages":[165],"invasion":[170],"through":[171],"tissue.":[174],"CONCLUSION:":[175],"Integrin-targeted":[176],"growth,":[180],"solely":[181],"targeting":[182,204],"host":[184],"angiogenesis.":[185],"This":[186],"strategy":[188],"should":[189],"be":[190],"further":[191],"exploited":[192],"use":[194],"combination":[196],"conventional":[198],"strategies,":[200],"or":[201],"combined":[203],"alternative":[206],"antiangiogenic":[207],"pathways.":[208]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2345469147","counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":3}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
